November 2016: FDA Approves Clinical Trial of Ecstasy
Here's a slideshow depicting the major science and disaster news events of November 2016.
1. Oklahoma Suffers 5.0 Earthquake 2. One Step Closer to Treatment, Vaccine for Zika 3. Earthquake and Tsunami Hit New Zealand 4. Wildfires Spread in Southeast U.S. 5. Scientists Announce Breakthrough in GMO Plants 6. Deadly Train Derailment in India 7. Bus Crash in Tennessee Kills Schoolchildren 8. Plane Carrying Brazilian Soccer Team Crashes 9. Zika Appears in Texas 10. Deadly Fires in Tennessee 11. Ecstasy Goes to Clinical Trials for PTSD Treatment
- FDA Approves Clinical Trial of Ecstasy
- On November 29, 2016, the Food and Drug Administration (FDA) approves large-scale, Phase 3 clinical trials of the "party drug" Ecstasy, or MDMA. If approved, the drug could become a prescription option for those struggling with Post Traumatic Stress Disorder (PTSD). Trials so far are promising and doctors believe the use of MDMA is necessary since current options only help 60-70% of people. There is concern about the connection between long-term use and brain damage.
- Photo source: AP Photo/Bullit Marquez